Plasma-based metabolomic and lipidomic analyses reveal the potential biomarker LPE 16:0 as predictor for treatment outcome in a depression study

Neuroscience Applied 2026 Open access

Read full text

Authors: C. Hohoff, S.M. Wissing, L. Steinbach, H. Althaus, T. Lange, S. Schuchardt, E. Van Assche, B.T. Baune

DOI: 10.1016/j.nsa.2025.105581

Cited by: 0

Fields of Study & Subjects

Metabolomics and Mass Spectrometry Studies Tryptophan and brain disorders Treatment of Major Depression